日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ketogenic therapy in childhood and adolescence: recommendations of the Brazilian experts group

儿童和青少年生酮疗法:巴西专家组的建议

de Brito Sampaio, Letícia Pereira; Henriques-Souza, Adélia Maria de Miranda; Lin, Katia; Neri, Lenycia de Cassya Lopes; Inuzuka, Luciana Midori; Uchôa, Ludmila Inácio de Lima; Gregório, Marcela Marques de Oliveira; Guilhoto, Laura Maria; Montenegro, Maria Augusta; Lunardi, Mariana; Veiga, Marielza; de Lima, Patricia Azevedo; Braatz, Vera

Creation of EGD-Derived Gastric Cancer Organoids to Predict Treatment Responses

创建 EGD 衍生的胃癌类器官来预测治疗反应

Hannah G McDonald, Megan M Harper, Kristen Hill, Anqi Gao, Angelica L Solomon, Charles J Bailey, Miranda Lin, Mautin Barry-Hundeyin, Michael J Cavnar, Samuel H Mardini, Prakash J Pandalai, Reema A Patel, Jill M Kolesar, Justin A Rueckert, Lawrence Hookey, Mark Ropeleski, Shaila J Merchant, Joseph Ki

Interaction of immune checkpoint PD-1 and chemokine receptor 4 (CXCR4) promotes a malignant phenotype in pancreatic cancer cells

免疫检查点 PD-1 与趋化因子受体 4 (CXCR4) 的相互作用促进胰腺癌细胞的恶性表型

Megan M Harper, Miranda Lin, Michael J Cavnar, Prakash K Pandalai, Reema A Patel, Mei Gao, Joseph Kim

Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application

开发单细胞技术以提高胃肠道癌症类器官的产量和用于个性化医疗应用

Mei Gao, Megan M Harper, Miranda Lin, Shadi A Qasem, Reema A Patel, Samuel H Mardini, Moamen M Gabr, Michael J Cavnar, Prakash K Pandalai, Joseph Kim

Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer

胰腺癌免疫检查点 PD-1 的直接治疗靶向

Mei Gao, Miranda Lin, Richard A Moffitt, Marcela A Salazar, Jinha Park, Jeffrey Vacirca, Chuan Huang, Kenneth R Shroyer, Minsig Choi, Georgios V Georgakis, Aaron R Sasson, Mark A Talamini, Joseph Kim